Conference Coverage
Conference Coverage
Spinal cord atrophy predicts ‘silent progression’ in MS
This is a potentially important biomarker for disease progression that may otherwise go unrecognized by clinicians and patients.
Conference Coverage
B-cell repletion is common with MS drug, but no symptom worsening
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
Conference Coverage
Brief, automated cognitive test may offer key advantages in MS
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or...
Conference Coverage
Specialty pharmacists may speed time to MS treatment
Because there currently is no established DMT selection algorithm, specialty pharmacists can assist in medication education and management.
Conference Coverage
Cannabis use common for MS-related spasticity
The new data reflect the latest patterns of use amid sweeping changes in recreational and medical marijuana laws.
Conference Coverage
New consensus guideline on clinical MRI use in MS
The updated protocol is beneficial in providing “simple, reasonable guidelines that can be easily acquired at almost any imaging location in the U...
Conference Coverage
Multiple DMTs linked to alopecia, especially in women
Several medications weren’t previously implicated in hair loss, researchers report.
Conference Coverage
Certain DMTs in MS linked to more psoriasis
Few cases overall were reported, but researchers still urge caution in drug selection.
Conference Coverage
Which agent is best for neuromyelitis optica?
Researchers conducted an indirect treatment comparison on the efficacy of the three FDA-approved treatment options for adults with AQP4+ NMOSD.
Conference Coverage
Two diets linked to improved cognition, fatigue in MS
These results are among the first to show diet-related favorable reductions in cognitive dysfunction.